These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9719206)

  • 1. Ultrafiltration behaviour with different dialysis schedules.
    Santoro A; Mancini E; Zucchelli P
    Nephrol Dial Transplant; 1998; 13 Suppl 6():55-61. PubMed ID: 9719206
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing dialysis by variation of ultrafiltration rate and sodium concentration controlled by continuous measurement of circulating blood volume.
    Mann H; Stiller S; Schallenberg U; Thömmes A
    Contrib Nephrol; 1989; 74():182-90. PubMed ID: 2702138
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of sodium and ultrafiltration modelling on plasma volume changes and haemodynamic stability in intensive care patients receiving haemodialysis for acute renal failure: a prospective, stratified, randomized, cross-over study.
    Paganini EP; Sandy D; Moreno L; Kozlowski L; Sakai K
    Nephrol Dial Transplant; 1996; 11 Suppl 8():32-7. PubMed ID: 9044338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium transport with different dialysis ultrafiltration schedules using a bio-feedback module (BFB).
    Di Giulio S; Meschini L; Friggi A; Stortoni F; Cherubini C; de Paolis P; Rosa M
    Nephrol Dial Transplant; 1998; 13 Suppl 6():39-42. PubMed ID: 9719203
    [No Abstract]   [Full Text] [Related]  

  • 5. Behaviour of acid-base control with different dialysis schedules.
    Feriani M
    Nephrol Dial Transplant; 1998; 13 Suppl 6():62-5. PubMed ID: 9719207
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics of intradialytic disequilibria: the problem, the causes, and new methods for the alleviation of patient morbidity.
    Kelly TD
    Nephrol Dial Transplant; 1996; 11 Suppl 8():3-9. PubMed ID: 9044333
    [No Abstract]   [Full Text] [Related]  

  • 7. Behaviour of beta2-microglobulin removal with different dialysis schedules.
    David S; Bottalico D; Tagliavini D; Mandolfo S; Scanziani R; Cambi V
    Nephrol Dial Transplant; 1998; 13 Suppl 6():49-54. PubMed ID: 9719205
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Zero-Balance Ultrafiltration With Dialysate as a Replacement Solution for Toxin and Eptifibatide Removal on a Dialysis-Dependent Patient During Cardiopulmonary Bypass.
    Heath M; Barbeito A; Welsby I; Maxwell C; Iribarne A; Raghunathan K
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):162-8. PubMed ID: 25857672
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous renal replacement therapies in the treatment of acute renal failure in intensive care patients. Part 1. Theoretical aspects and techniques.
    Ronco C
    Nephrol Dial Transplant; 1994; 9 Suppl 4():191-200. PubMed ID: 7800257
    [No Abstract]   [Full Text] [Related]  

  • 11. Less symptomatic hypotension using blood volume controlled ultrafiltration.
    Stiller S; Wirtz D; Waterbär F; Gladziwa U; Dakshinamurty KV; Mann H
    ASAIO Trans; 1991; 37(3):M139-41. PubMed ID: 1751083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood volume change during isolated ultrafiltration and combined ultrafiltration-dialysis.
    Fleming SJ; Wilkinson JS; Aldridge C; Greenwood RN; Baker LR; Cattell WR
    Nephrol Dial Transplant; 1988; 3(3):272-6. PubMed ID: 3140100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High peritoneal residual volume decreases the efficiency of peritoneal dialysis.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of sequential ultrafiltration and varying dialysate sodium on vascular stability during hemodialysis.
    Po CL; Afolabi M; Raja RM
    ASAIO J; 1993; 39(3):M798-800. PubMed ID: 8268648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous renal replacement therapies: the need for a standard nomenclature.
    Ronco C; Bellomo R
    Contrib Nephrol; 1995; 116():28-33. PubMed ID: 8529378
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glucose polymer (icodextrin) as a component of fluid for peritoneal dialysis].
    Czyzewska K; Szary B; Grzegorzewska A
    Pol Arch Med Wewn; 1998 May; 99(5):417-22. PubMed ID: 9816893
    [No Abstract]   [Full Text] [Related]  

  • 18. Slow continuous ultrafiltration with bound solute dialysis.
    Patzer JF; Safta SA; Miller RH
    ASAIO J; 2006; 52(1):47-58. PubMed ID: 16436890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid-base balance and replacement solutions in continuous renal replacement therapies.
    Feriani M; Dell'Aquila R
    Kidney Int Suppl; 1998 May; 66():S156-9. PubMed ID: 9573594
    [No Abstract]   [Full Text] [Related]  

  • 20. Increase in blood volume during dialysis without ultrafiltration.
    Nette RW; Akçahüseyin E; Krepel HP; Weimar W; Zietse R
    Blood Purif; 2001; 19(1):33-8. PubMed ID: 11114575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.